EBEmily A. Berthiaume

Emily A. Berthiaume

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Emily A. Berthiaume has a total of 140 co-authors. Here are the top co-authors by number of shared publications:

  • Chia Soo

    Division of Plastic and Reconstructive Surgery, Department of Orthopaedic Surgery, Orthopaedic Hospital Research Center, University of California, Los Angeles, CA, USA

    7 shared publications
  • Kang Ting

    Department of Orthopaedic Surgery and the Orthopaedic Hospital Research Center, UCLA and Orthopaedic Hospital, University of California, Los Angeles, California, 90095, USA

    6 shared publications
  • Chenshuang Li

    Department of Orthodontics, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA

    5 shared publications
  • Wenlu Jiang

    Division of Growth and Development, School of Dentistry, and

    4 shared publications
  • Xinli Zhang

    Dental and Craniofacial Research Institute and Section of Orthodontics, School of Dentistry, University of California, Los Angeles, Los Angeles, California

    4 shared publications
  • Zhong Zheng

    Department of Periodontics, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA

    4 shared publications

Latest Publications

  • Selective C4–5 Foraminotomy for Severe Foraminal Stenosis is Not Associated with Lower Rates of C5 Palsy After Posterior Cervical Decompression and Fusion

    by Roy Y. Miloh, Sulaiman Hashemi, Emily Berthiaume, Mitchell K. Ng, Joshua Mathew, Dipti Venkatesh, Grace Devany, Kiley Hammou, Robert J. Oris, Jonathan Dalton, et al.

  • Open Access

    The Impact of Hip Osteoarthritis on Patient Reported Outcomes Following Lumbar Fusion

    by Ali Farooqi, Joshua Mathew, Mitchell Ng, Roy Miloh, Emily Berthiaume, Yulia Lee, Gregorio Baek, William Green, Morgan Hitchner, Yasmine Eichbaum, et al.

    Study Design: Retrospective Cohort Study. Objectives: With an aging population, the burden of concomitant joint disease continues to rise. The effects of hip OA on lumbar fusion outcomes are underexplored. Therefore, this study aimed to: (1) describe demographic differences between Osteoarthritis (OA) patients and those without OA; (2) assess perioperative differences; and (3) compare patient-reported outcome measures (PROMs). Methods: A retrospective review of a single academic tertiary center was performed (2016-2025). Patients undergoing lumbar fusion with isolated hip OA or no diagnosis of OA, and 12-month ODI scores were included. Patients with prior arthroplasty were excluded. Kellgren-Lawrence scores were collected through chart review or graded on x-ray when missing. Patients were stratified based on the presence of Hip OA. Bivariate comparison was performed as appropriate. Multivariable regressions were performed to identify independent predictors of PROMs. Results: A total of 271 patients were included (No OA: 229; OA: 42). There were significant differences between groups regarding age (71.8 versus 60.2 years, P P =0.025), and smoking status ( P 0.05). Conclusions: These findings suggest that concomitant hip OA may not independently impact postoperative recovery and should not be considered a contraindication to lumbar fusion.

  • Open Access

    Response to the Letter to the Editor: “Ankylosing Spondylitis and Diffuse Idiopathic Skeletal Hyperostosis: Unaddressed Confounders in Postoperative Outcome Studies”

    by Abdullah Mahmood, Mitchell K. Ng, Emily Berthiaume, Adam Fano, Joydeep Baidya, Gregorio Baek, Jeffrey A. Rihn, Ian David Kaye, Thomas D. Cha, Jose A. Canseco, et al.

  • Open Access

    Effect of Interbody Composition on the Development of Pseudarthrosis Following Anterior Cervical Discectomy and Fusion

    by Nicholas D’aNtonio, Mark James Lambrechts, Jeremy Heard, Emily Bertiaume, Gregory Toci, Brian Karamian, Garrett Breyer, John Bodnar, Jose Canseco, Alan Hilibrand, et al.

    Study Design: Retrospective cohort study.Purpose: To determine if polyetheretherketone (PEEK) or titanium alloy cages increase the rate of pseudarthrosis development or revision surgery rate compared with structural allograft following anterior cervical discectomy and fusion (ACDF) and identify if the cage type results in differences in patient-reported outcome measures (PROMs) versus structural allograft.Overview of Literature: PEEK and titanium alloy cages have become popular options for ACDF intervertebral spacers. However, while data is beginning to emerge on how cage types affect arthrodesis rates, the effect of their composition on PROMs is less clear.Methods: All patients aged >18 years who underwent primary one- to four-level ACDF at a single institution were retrospectively identified. Propensity matching was performed to compare patients’ PEEK or titanium alloy cages with structural allograft. Multivariate logistic regression analysis was performed to measure the effect of interbody spacer composition on the likelihood of pseudarthrosis development.Results: Of the 502 patients who received structural allograft and had 1-year postoperative dynamic radiographs, 96 patients were propensity matched to 32 patients who received a PEEK cage, and 162 patients were propensity matched to 54 patients who received a titanium alloy cage. Multivariate logistic regression analysis identified that PEEK cage implants (odds ratio [OR], 3.34; p =0.007) predicted pseudarthrosis development compared with structural allograft implantation. Titanium alloy cage (OR, 1.64; p =0.156) implantation was not predictive of pseudarthrosis. One-year postoperative PROMs were not significantly different between patients who received PEEK or titanium alloy cages and those who received structural allograft (all p >0.05).Conclusions: Compared with structural allograft, receiving a PEEK cage increased the risk of pseudarthrosis development following ACDF, whereas receiving a titanium alloy cage had no significant effect on pseudarthrosis development. One-year postoperative patient-reported outcomes were similar between patients who received structural allograft, PEEK, and titanium alloy interbody spacers.


  • Neural EGFL like 1 as a potential pro-chondrogenic, anti-inflammatory dual-functional disease-modifying osteoarthritis drug

    by Chenshuang Li, Zhong Zheng, Pin Ha, Wenlu Jiang, Emily A. Berthiaume, Seungjun Lee, Zane Mills, Hsinchuan Pan, Eric C. Chen, Jie Jiang, et al.


  • Evaluating Current Scar Assessment Methods

    by Kelsey Lipman, Maxwell Wang, Emily Berthiaume, Janell Holloway, Andrew Da Lio, Kang Ting, Chia Soo, Zhong Zheng

    Current scar surveys have included many questions to evaluate the physical characteristics of scars, with some expanding to include physical implications and patient opinions. This review provides an analysis of frequently used scar assessment methods to date and highlights potential areas for improvement. We build the case that a new assessment tool is necessary, specifically one that centers on psychosocial consequences of scars that influence patient decision making for treatment, allowing physicians to individualize treatment conversations with patients. We postulate that survey techniques used in consumer product marketing, such as choice-based conjoint analysis, may be effective in determining the factors strongly influencing patient decision making and spending in scar treatment; therefore, more research in this area is warranted. By incorporating these psychosocial and economic considerations driving scar treatment decisions, future scar assessment tools may accomplish much more than characterizing/documenting the clinical aspects of scars. Rather, these patient-centered, holistic tools may be implemented by plastic surgeons and other clinicians specifically to provide patients with personalized treatment options that maximize long-term patient satisfaction.


  • CDKN2B upregulation prevents teratoma formation in multipotent fibromodulin-reprogrammed cells

    by Zhong Zheng, Chenshuang Li, Pin Ha, Grace X. Chang, Pu Yang, Xinli Zhang, Jong Kil Kim, Wenlu Jiang, Xiaoxiao Pang, Emily A. Berthiaume, et al.

    Tumorigenicity is a well-documented risk to overcome for pluripotent or multipotent cell applications in regenerative medicine. To address the emerging demand for safe cell sources in tissue regeneration, we established a novel, protein-based reprogramming method that does not require genome integration or oncogene activation to yield multipotent fibromodulin (FMOD)-reprogrammed (FReP) cells from dermal fibroblasts. When compared with induced pluripotent stem cells (iPSCs), FReP cells exhibited a superior capability for bone and skeletal muscle regeneration with markedly less tumorigenic risk. Moreover, we showed that the decreased tumorigenicity of FReP cells was directly related to an upregulation of cyclin-dependent kinase inhibitor 2B (CDKN2B) expression during the FMOD reprogramming process. Indeed, sustained suppression of CDKN2B resulted in tumorigenic, pluripotent FReP cells that formed teratomas in vivo that were indistinguishable from iPSC-derived teratomas. These results highlight the pivotal role of CDKN2B in cell fate determination and tumorigenic regulation and reveal an alternative pluripotent/multipotent cell reprogramming strategy that solely uses FMOD protein.


  • Peroxisome Proliferator-Activated Receptor-γ Knockdown Impairs Bone Morphogenetic Protein-2–Induced Critical-Size Bone Defect Repair

    by Chenchao Wang, Justine Tanjaya, Jia Shen, Soonchul Lee, Bharti Bisht, Hsin Chuan Pan, Shen Pang, Yulong Zhang, Emily A. Berthiaume, Eric Chen, et al.


  • Surgical Repair of an Avulsed Distal Flexor Carpi Radialis Tendon in a Boxer

    by Emily A. Berthiaume, Thomas M. Hagopian, Myles J. Cohen, Eric S. Millstein, David A. Kulber

    Case: A 25-year-old professional boxer presented with a right distal flexor carpi radialis (FCR) tendon avulsion after sustaining an injury while boxing. The avulsion was identified and confirmed with magnetic resonance imaging, and the tendon was successfully reinserted into the trapezium. The patient returned to professional boxing 10 months later without complication. Conclusions: Distal FCR tendon avulsions are rare. Occasionally, this tendon can avulse after an application of excessive force. For some patients, unrepaired distal FCR tendon avulsions may prevent competitive performance. In this case, the tendon was reattached to the trapezium to aid wrist motion and stability, which are essential for professional boxing.


  • Open Access

    Neurexin Superfamily Cell Membrane Receptor Contactin-Associated Protein Like-4 (Cntnap4) Is Involved in Neural EGFL-Like 1 (Nell-1)-Responsive Osteogenesis

    by Chenshuang Li, Zhong Zheng, Pin Ha, Xiaoyan Chen, Wenlu Jiang, Shan Sun, Feng Chen, Greg Asatrian, Emily A Berthiaume, Jong Kil Kim, et al.

    Contactin‐associated protein‐like 4 (Cntnap4) is a member of the neurexin superfamily of transmembrane molecules that have critical functions in neuronal cell communication. Cntnap4 knockout mice display decreased presynaptic gamma‐aminobutyric acid (GABA) and increased dopamine release that is associated with severe, highly penetrant, repetitive, and perseverative movements commonly found in human autism spectrum disorder patients. However, no known function of Cntnap4 has been revealed besides the nervous system. Meanwhile, secretory protein neural EGFL‐like 1 (Nell‐1) is known to exert potent osteogenic effects in multiple small and large animal models without the off‐target effects commonly found with bone morphogenetic protein 2. In this study, while searching for a Nell‐1‐specific cell surface receptor during osteogenesis, we identified and validated a ligand/receptor‐like interaction between Nell‐1 and Cntnap4 by demonstrating: 1) Nell‐1 and Cntnap4 colocalization on the surface of osteogenic‐committed cells; 2) high‐affinity interaction between Nell‐1 and Cntnap4; 3) abrogation of Nell‐1‐responsive Wnt and MAPK signaling transduction, as well as osteogenic effects, via Cntnap4 knockdown; and 4) replication of calvarial cleidocranial dysplasias‐like defects observed in Nell‐1‐deficient mice in Wnt1‐Cre‐mediated Cntnap4‐knockout transgenic mice. In aggregate, these findings indicate that Cntnap4 plays a critical role in Nell‐1‐responsive osteogenesis. Further, this is the first functional annotation for Cntnap4 in the musculoskeletal system. Intriguingly, Nell‐1 and Cntnap4 also colocalize on the surface of human hippocampal interneurons, implicating Nell‐1 as a potential novel ligand for Cntnap4 in the nervous system. This unexpected characterization of the ligand/receptor‐like interaction between Nell‐1 and Cntnap4 indicates a novel biological functional axis for Nell‐1 and Cntnap4 in osteogenesis and, potentially, in neural development and function. © 2018 American Society for Bone and Mineral Research.